Zhu Y - Search Results

1

NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden.

Li Z, Zheng Y, Wu Z, Zhuo T, Zhu Y, Dai L, Wang Y, Chen M. Li Z, et al. Among authors: zhu y. Medicine (Baltimore). 2023 Jan 20;102(3):e32686. doi: 10.1097/MD.0000000000032686. Medicine (Baltimore). 2023. PMID: 36701707 Free PMC article.

2

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.

Liu B, Liu Z, Wang Y, Lian X, Han Z, Cheng X, Zhu Y, Liu R, Zhao Y, Gao Y. Liu B, et al. Among authors: zhu y. Mol Med. 2021 Sep 23;27(1):117. doi: 10.1186/s10020-021-00378-0. Mol Med. 2021. PMID: 34556022 Free PMC article.

3

SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma.

Li Z, He L, Li J, Qian J, Wu Z, Zhu Y, Zhuo T, Nong J, Liang H, Zheng H, Huang W, Huang J, Cao J. Li Z, et al. Among authors: zhu y. Clin Exp Med. 2024 Oct 24;24(1):243. doi: 10.1007/s10238-024-01510-0. Clin Exp Med. 2024. PMID: 39443355 Free PMC article.

4

Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma.

Liu Z, Cheng X, Pang B, Wang S, Liu B, Cao C, Qian R, Liang W, Zhu Y, Li P, Gao Y. Liu Z, et al. Among authors: zhu y. Int Immunopharmacol. 2022 Mar;104:108399. doi: 10.1016/j.intimp.2021.108399. Epub 2022 Jan 8. Int Immunopharmacol. 2022. PMID: 35008004

5

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma.

Liu Z, Lian X, Zhang X, Zhu Y, Zhang W, Wang J, Wang H, Liu B, Ren Z, Zhang M, Liu M, Gao Y. Liu Z, et al. Among authors: zhu y. Front Genet. 2021 Aug 26;12:666106. doi: 10.3389/fgene.2021.666106. eCollection 2021. Front Genet. 2021. PMID: 34512713 Free PMC article.

6

Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.

Zhang B, Yao J, Lian X, Liu B, Wang Y, Wang H, Wang J, Zhang M, Zhao Y, Zhu Y, Liu R, Gao Y. Zhang B, et al. Among authors: zhu y. Mol Clin Oncol. 2021 Sep;15(3):171. doi: 10.3892/mco.2021.2333. Epub 2021 Jun 29. Mol Clin Oncol. 2021. PMID: 34276990 Free PMC article.

7

Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis.

Zhu Y, Liu Z, Lv D, Cheng X, Wang J, Liu B, Han Z, Wang Y, Liu R, Gao Y. Zhu Y, et al. Future Oncol. 2022 Feb;18(5):579-596. doi: 10.2217/fon-2021-0759. Epub 2022 Jan 17. Future Oncol. 2022. PMID: 35037470

8

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma.

Liu R, Liu Z, Zhao Y, Cheng X, Liu B, Wang Y, Wang J, Lian X, Zhu Y, Gao Y. Liu R, et al. Among authors: zhu y. Front Oncol. 2022 Jul 19;12:726556. doi: 10.3389/fonc.2022.726556. eCollection 2022. Front Oncol. 2022. PMID: 35928884 Free PMC article.

9

Food Insecurity in Pregnancy, Receipt of Food Assistance, and Perinatal Complications.

Chehab RF, Croen LA, Laraia BA, Greenberg MB, Ngo AL, Ferrara A, Zhu Y. Chehab RF, et al. Among authors: zhu y. JAMA Netw Open. 2025 Jan 2;8(1):e2455955. doi: 10.1001/jamanetworkopen.2024.55955. JAMA Netw Open. 2025. PMID: 39847356

10

Prediction models for the complication incidence and survival rate of dental implants-a systematic review and critical appraisal.

Zhu Y, Du M, Li P, Lu H, Li A, Xu S. Zhu Y, et al. Int J Implant Dent. 2025 Jan 23;11(1):5. doi: 10.1186/s40729-025-00590-1. Int J Implant Dent. 2025. PMID: 39847174 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,262 results

Search Page

Filters